These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30843890)

  • 21. Burkitt lymphoma in adults.
    Linch DC
    Br J Haematol; 2012 Mar; 156(6):693-703. PubMed ID: 21923642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
    Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H
    Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
    van Imhoff GW; van der Holt B; MacKenzie MA; Ossenkoppele GJ; Wijermans PW; Kramer MH; van 't Veer MB; Schouten HC; van Marwijk Kooy M; van Oers MH; Raemaekers JM; Sonneveld P; Meulendijks LA; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
    Leukemia; 2005 Jun; 19(6):945-52. PubMed ID: 15800666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gingival Burkitt lymphoma in a hepatitis C-positive renal transplant patient].
    Unholzer A; Starz H; Hirschsteiner O; Balda BR
    J Dtsch Dermatol Ges; 2005 Jan; 3(1):46-51. PubMed ID: 16353750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.
    Lamar ZS; Fino N; Palmer J; Gruber L; Morris BB; Raetskaya-Solntseva O; Kennedy L; Vaidya R; Hurd D; Zamkoff K
    Clin Lymphoma Myeloma Leuk; 2016 Feb; 16(2):76-81. PubMed ID: 26725264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Successful treatment with dose-adjusted EPOCH-R for triple-hit lymphoma having BCL2, BCL6 and MYC translocations].
    Hashimoto A; Fujimi A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Matsumoto T; Shibata T; Hamaguchi K; Kamihara Y; Iwasaki S; Kato J
    Rinsho Ketsueki; 2015 Jul; 56(7):905-10. PubMed ID: 26256929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult Burkitt leukemia and lymphoma.
    Blum KA; Lozanski G; Byrd JC
    Blood; 2004 Nov; 104(10):3009-20. PubMed ID: 15265787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study.
    Xiao J; Du S; Dai G; Gao G; Yang D; Zhao H
    Sci Rep; 2017 May; 7(1):1905. PubMed ID: 28507339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
    Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F
    J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
    Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Burkitt's lymphoma].
    Afanas N; Carvalho M; Almeida M; Costa V; Silva I; Oliva T
    Acta Med Port; 2011; 24(5):735-8. PubMed ID: 22525625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burkitt lymphoma presenting as a mass in the thyroid gland: a clinicopathologic study of 7 cases and review of the literature.
    Quesada AE; Liu H; Miranda RN; Golardi N; Billah S; Medeiros LJ; Jaso JM
    Hum Pathol; 2016 Oct; 56():101-8. PubMed ID: 27257042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posterior Reversible Encephalopathy Syndrome Associated With Dose-adjusted EPOCH (Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin) Chemotherapy.
    Floeter AE; Patel A; Tran M; Chamberlain MC; Hendrie PC; Gopal AK; Cassaday RD
    Clin Lymphoma Myeloma Leuk; 2017 Apr; 17(4):225-230. PubMed ID: 28169156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
    Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged low intensity EPOCH-rituximab has improved toxicity in Burkitt lymphoma compared with standard short, high intensity therapy.
    Shahbazi S; Peer CJ; Figg WD
    Cancer Biol Ther; 2014 Sep; 15(9):1117-9. PubMed ID: 24919059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkitt lymphoma in adolescents and young adults: management challenges.
    Dozzo M; Carobolante F; Donisi PM; Scattolin A; Maino E; Sancetta R; Viero P; Bassan R
    Adolesc Health Med Ther; 2017; 8():11-29. PubMed ID: 28096698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience.
    Jang SJ; Yoon DH; Kim S; Yoon S; Kim DY; Park CS; Huh J; Lee SW; Lee DH; Ryu JS; Suh C
    Ann Hematol; 2012 Dec; 91(12):1917-22. PubMed ID: 22864762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
    Evens AM; Kanakry JA; Sehn LH; Kritharis A; Feldman T; Kroll A; Gascoyne RD; Abramson JS; Petrich AM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Adeimy C; Hemminger J; Bartlett NL; Mato A; Caimi PF; Advani RH; Klein AK; Nabhan C; Smith SM; Fabregas JC; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA
    Am J Hematol; 2015 Sep; 90(9):778-83. PubMed ID: 26044261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burkitt's lymphoma/leukemia: a clinicopathologic study on 24 adult patients.
    Bernasconi C; Brusamolino E; Pagnucco G; Bernasconi P; Orlandi E; Lazzarino M
    Leukemia; 1991; 5 Suppl 1():90-4. PubMed ID: 1890873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
    Suzuki K; Nakazato T; Sanada Y; Mihara A; Tachikawa N; Kurai H; Yoshimura Y; Hayashi H; Yoshida S; Kakimoto T
    Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.